172
Participants
Start Date
September 29, 2017
Primary Completion Date
October 27, 2018
Study Completion Date
October 27, 2018
Theranova 400 dialyzer
Patients should continue with their pre-study hemodialysis prescriptions (in terms of treatment time, blood flow rate and dialysate flow rate) and prescriptions should be kept stable throughout the study.
Elisio-17H dialyzer
Patients should continue with their pre-study hemodialysis prescriptions (in terms of treatment time, blood flow rate and dialysate flow rate) and prescriptions should be kept stable throughout the study.
DaVita Inc., Bronx Dialysis Center, The Bronx
Dialysis Center, Inc. Philidelphia, Philadelphia
DaVita Inc., Norfolk Dialysis, Chesapeake
Dialysis Center, Inc. Albany, Albany
Dialysis Center, Inc. Holston River Clinic, Knoxville
Dialysis Center, Inc. Kidney Associates of Kansas City, Belton
Dialysis Center of Lincoln, Lincoln
DaVita Renal Center of Lewisville, Lewisville
DaVita Inc., Medical Center Dialysis, Houston
DaVita Inc., Northwest Medical Center Dialysis, San Antonio
DaVita Floyd Curl Dialysis, San Antonio
DaVita Inc., Transmountain Dialysis, El Paso
DaVita Five Star Dialysis Center, Las Vegas
DaVita Inc., South Las Vegas Dialysis, Las Vegas
DaVita Riverside, Riverside
DaVita Corona, Corona
DaVita Inc, Greater Hartford Nephrology, Bloomfield
DaVita Inc., Waterbury Dialysis, Middlebury
Dialysis Center, Inc. Boston, Boston
Dialysis Center, Inc. North Brunswick, North Brunswick
Baxter Healthcare Corporation
INDUSTRY
Vantive Health LLC
INDUSTRY